📰 Quest Diagnostics News
Page 38 - Quest Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Quest Diagnostics. Real-time updates on events, politics, business and more.
April 26, 2024
* Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston * Funding will also support film screening tour of award-winning...
April 26, 2024
Quest Diagnostics (NYSE:DGX – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 8.720-8.970 for the period, compared to the consensus EPS estimate of 8.750. The company issued revenue guidance of $9.4 billion-$9.5 billion, compared to the consensus revenue estimate of $9.4 billion. […]
April 26, 2024
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...
April 26, 2024
Comprehensive SWOT Analysis: Quest Diagnostics Inc's Financial and Strategic Position
April 26, 2024
A paper published in The Journal of Nutrition makes the case for increased diagnostic testing to improve omega-3 status and related health outcomes around the world.
April 26, 2024
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration ...
April 26, 2024
Cwm LLC increased its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,200 shares of the medical research company’s stock after purchasing an additional 232 shares during the period. […]
April 26, 2024
Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston; funding will also support film screening tour of award-winning documentary to highlight importance of health equity through STEM-based nutrition educationSECAUCUS, NJ, and BRONX, NY / ACCE...
April 26, 2024
Quest Diagnostics (NYSE:DGX – Free Report) had its price objective increased by Barclays from $138.00 to $144.00 in a report released on Thursday morning, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other brokerages have also issued reports on DGX. StockNews.com raised shares of Quest Diagnostics from […]
April 26, 2024
Plus 19 other New Jersey companies among the best in the U.S.